Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Traditional Chinese Medicine and Ranibizumab in the Treatment of Macular Cystoid Edema Associated With Retinal Vein Obstruction.

NCT06234514 is registered in ClinicalTrials.gov with Dongyang People's Hospital as lead sponsor.

NCT NCT06234514
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06234514 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Traditional Chinese Medicine and Ranibizumab in the Treatment of Macular Cystoid Edema Associated With Retinal Vein Obstruction.
Lead sponsor
Dongyang People's Hospital
Phase
Phase 4
Overall status
Completed
Start date
January 1, 2023
Completion date
May 31, 2025
Enrollment
111 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

macular cystoid edema